Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.200
+0.160 (3.96%)
At close: Apr 28, 2026, 4:00 PM EDT
4.210
+0.010 (0.24%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Ironwood Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Ironwood Pharmaceuticals stock have an average target of 7.67, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 82.62% from the current stock price of 4.20.
Analyst Consensus: Buy
* Price targets were last updated on Feb 26, 2026.
Analyst Ratings
The average analyst rating for Ironwood Pharmaceuticals stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +138.10% | Feb 26, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $3 → $5 | Hold | Maintains | $3 → $5 | +19.05% | Jan 5, 2026 |
| Citizens | Citizens | Hold → Buy Upgrades $8 | Hold → Buy | Upgrades | $8 | +90.48% | Jan 5, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $1 → $3 | Hold | Maintains | $1 → $3 | -28.57% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $7 → $1 | Buy → Hold | Downgrades | $7 → $1 | -76.19% | Apr 15, 2025 |
Financial Forecast
Revenue This Year
467.77M
from 296.15M
Increased by 57.95%
Revenue Next Year
488.30M
from 467.77M
Increased by 4.39%
EPS This Year
1.38
from 0.15
Increased by 827.92%
EPS Next Year
1.49
from 1.38
Increased by 7.90%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 486.9M | 516.1M | ||||||
| Avg | 467.8M | 488.3M | ||||||
| Low | 442.9M | 457.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 64.4% | 10.3% | ||||||
| Avg | 57.9% | 4.4% | ||||||
| Low | 49.6% | -2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.83 | 1.83 | ||||||
| Avg | 1.38 | 1.49 | ||||||
| Low | 1.13 | 1.27 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1,131.2% | 32.7% | ||||||
| Avg | 827.9% | 7.9% | ||||||
| Low | 659.4% | -7.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.